Literature DB >> 19737228

Coagulation activation in autoimmune bullous diseases.

A V Marzano1, A Tedeschi, D Spinelli, D Fanoni, C Crosti, M Cugno.   

Abstract

The main autoimmune blistering skin disorders are pemphigus vulgaris (PV) and bullous pemphigoid (BP). They differ in the inflammatory infiltrate, which is more intense in BP. Inflammation is known to activate coagulation in several disorders. Local and systemic activation of coagulation was evaluated in BP and PV. We studied 20 BP patients (10 active and 10 remittent), 23 PV patients (13 active and 10 remittent) and 10 healthy subjects. The coagulation markers prothrombin fragment F1+2 and D-dimer were measured by enzyme-immunoassays in plasma. The presence of tissue factor (TF), the main initiator of blood coagulation, was evaluated immunohistochemically in skin specimens from 10 patients with active PV, 10 patients with active BP and 10 controls. Plasma F1+2 and D-dimer levels were significantly high in active BP (P = 0.001), whereas in active PV the levels were normal. During remission, F1+2 and D-dimer plasma levels were normal in both BP and PV. TF immunoreactivity was found in active BP but neither in active PV nor in normal skin. TF reactivity scores were higher in active BP than in controls or active PV (P = 0.0001). No difference in TF scores was found between active PV and controls. BP is associated with coagulation activation, which is lacking in PV. This suggests that BP but not PV patients have an increased thrombotic risk. The observation that thrombotic complications occur more frequently in BP than in PV further supports this view.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19737228      PMCID: PMC2759056          DOI: 10.1111/j.1365-2249.2009.03989.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  31 in total

Review 1.  Two-way interactions between inflammation and coagulation.

Authors:  Marcel Levi; Tom van der Poll
Journal:  Trends Cardiovasc Med       Date:  2005-10       Impact factor: 6.677

2.  Severe venous thromboembolic disease in Churg-Strauss syndrome.

Authors:  G Garcia; L Achouh; D Cobarzan; D Fichet; M Humbert
Journal:  Allergy       Date:  2005-03       Impact factor: 13.146

3.  Role of cell-mediated immune reaction in blister formation of bullous pemphigoid.

Authors:  F Kaneko; T Minagawa; Y Takiguchi; M Suzuki; N Itoh
Journal:  Dermatology       Date:  1992       Impact factor: 5.366

4.  Characterization of skin cytokines in bullous pemphigoid and pemphigus vulgaris.

Authors:  M J Rico; C Benning; E S Weingart; R D Streilein; R P Hall
Journal:  Br J Dermatol       Date:  1999-06       Impact factor: 9.302

5.  The pathophysiology of autoimmune blistering diseases.

Authors:  Kim B Yancey
Journal:  J Clin Invest       Date:  2005-04       Impact factor: 14.808

6.  Recognition of desmoglein 3 by autoreactive T cells in pemphigus vulgaris patients and normals.

Authors:  M Hertl; M Amagai; H Sundaram; J Stanley; K Ishii; S I Katz
Journal:  J Invest Dermatol       Date:  1998-01       Impact factor: 8.551

Review 7.  Tissue factor mediates inflammation.

Authors:  Arthur J Chu
Journal:  Arch Biochem Biophys       Date:  2005-08-15       Impact factor: 4.013

8.  The role of complement in experimental bullous pemphigoid.

Authors:  Z Liu; G J Giudice; S J Swartz; J A Fairley; G O Till; J L Troy; L A Diaz
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

9.  Patients with severe sepsis vary markedly in their ability to generate activated protein C.

Authors:  Patricia C Y Liaw; Charles T Esmon; Kamyar Kahnamoui; Shelley Schmidt; Sarah Kahnamoui; Gary Ferrell; Suzanne Beaudin; Jim A Julian; Jeffrey I Weitz; Mark Crowther; Mark Loeb; Deborah Cook
Journal:  Blood       Date:  2004-08-19       Impact factor: 22.113

10.  Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls.

Authors:  L Büdinger; L Borradori; C Yee; R Eming; S Ferencik; H Grosse-Wilde; H F Merk; K Yancey; M Hertl
Journal:  J Clin Invest       Date:  1998-12-15       Impact factor: 14.808

View more
  9 in total

1.  Activation of blood coagulation in chronic urticaria: pathophysiological and clinical implications. [corrected]

Authors:  Marco Cicardi
Journal:  Intern Emerg Med       Date:  2010-03-27       Impact factor: 3.397

2.  Activation of coagulation in bullous pemphigoid and other eosinophil-related inflammatory skin diseases.

Authors:  A V Marzano; A Tedeschi; E Berti; D Fanoni; C Crosti; M Cugno
Journal:  Clin Exp Immunol       Date:  2011-04-13       Impact factor: 4.330

3.  Prothrombotic state and impaired fibrinolysis in bullous pemphigoid, the most frequent autoimmune blistering disease.

Authors:  A V Marzano; A Tedeschi; I Polloni; C Crosti; M Cugno
Journal:  Clin Exp Immunol       Date:  2013-01       Impact factor: 4.330

4.  Tissue Factor in Dermatitis Herpetiformis and Bullous Pemphigoid: Link between Immune and Coagulation System in Subepidermal Autoimmune Bullous Diseases.

Authors:  Agnieszka Zebrowska; Malgorzata Wagrowska-Danilewicz; Marian Danilewicz; Joanna Wieczfinska; Ewa Pniewska; Michal Zebrowski; Elzbieta Waszczykowska; Anna Wozniacka; Makandjou-Ola Eusebio; Miroslawa Pietruczuk; Rafal Pawliczak
Journal:  Mediators Inflamm       Date:  2015-12-29       Impact factor: 4.711

Review 5.  Coagulation and Skin Autoimmunity.

Authors:  Massimo Cugno; Alessandro Borghi; Simone Garcovich; Angelo Valerio Marzano
Journal:  Front Immunol       Date:  2019-06-20       Impact factor: 7.561

Review 6.  New Insights Into the Pathogenesis of Bullous Pemphigoid: 2019 Update.

Authors:  Giovanni Genovese; Giovanni Di Zenzo; Emanuele Cozzani; Emilio Berti; Massimo Cugno; Angelo Valerio Marzano
Journal:  Front Immunol       Date:  2019-07-02       Impact factor: 7.561

7.  The Risk of Pulmonary Embolism in Patients With Pemphigus: A Population-Based Large-Scale Longitudinal Study.

Authors:  Khalaf Kridin; Mouhammad Kridin; Kyle T Amber; Guy Shalom; Doron Comaneshter; Erez Batat; Arnon D Cohen
Journal:  Front Immunol       Date:  2019-07-24       Impact factor: 7.561

8.  Recurrent venous thrombosis in an adequately anticoagulated patient with pemphigus vulgaris.

Authors:  Paul R J Ames; Maria Graf; Fabrizio Gentile
Journal:  Thromb J       Date:  2016-03-04

Review 9.  Bullous Pemphigoid: Trigger and Predisposing Factors.

Authors:  Francesco Moro; Luca Fania; Jo Linda Maria Sinagra; Adele Salemme; Giovanni Di Zenzo
Journal:  Biomolecules       Date:  2020-10-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.